Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)

Historical Holders from Q1 2016 to Q1 2025

Symbol
CRVS on Nasdaq
CUSIP
221015100
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
68M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
37.7M
Holdings value
$202M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
90
Number of buys
53
Number of sells
-19
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SAMLYN CAPITAL, LLC 9.8% $21.2M 6.67M Samlyn Capital, LLC Dec 31, 2024
MILLER RICHARD A MD 7.7% $16.6M 5.22M Richard A. Miller Dec 31, 2024

Institutional Holders of Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 153K $487K +$63.6K $3.18 7
2024 Q4 37.7M $202M +$34.4M $5.35 90
2024 Q3 30M $159M +$12.7M $5.28 64
2024 Q2 27.6M $50.2M +$17.7M $1.82 46
2024 Q1 17.9M $31.9M -$2.31M $1.78 47
2023 Q4 19.2M $33.8M -$27.3K $1.76 46
2023 Q3 19.2M $28M -$1.23M $1.46 52
2023 Q2 19.5M $44.6M +$735K $2.29 51
2023 Q1 20.8M $18.9M -$164K $0.91 35
2022 Q4 21.3M $18.1M -$597K $0.85 37
2022 Q3 22M $18M -$3.3M $0.82 36
2022 Q2 25.5M $25.3M -$3.29M $0.99 37
2022 Q1 27.4M $44.9M -$1.21M $1.64 49
2021 Q4 27.7M $66.7M -$7.83M $2.41 58
2021 Q3 28.2M $136M +$22.8M $4.84 56
2021 Q2 23.7M $63.2M +$8.57M $2.67 44
2021 Q1 20.4M $62.8M +$12.1M $3.08 47
2020 Q4 16.3M $58.1M -$3.25M $3.56 34
2020 Q3 16.6M $66.6M -$11.8M $4.01 32
2020 Q2 20.4M $55.6M -$392K $2.72 33
2020 Q1 20.7M $43.6M -$3.31M $2.11 36
2019 Q4 20.8M $113M -$10.4M $5.44 35
2019 Q3 22.9M $68.9M -$4.06M $3.01 34
2019 Q2 24.3M $91M -$1.48M $3.74 43
2019 Q1 24.6M $98.8M -$918K $4.02 55
2018 Q4 25.1M $92.2M -$2.05M $3.67 59
2018 Q3 25.5M $218M -$3.36M $8.58 57
2018 Q2 25.9M $284M +$903K $10.98 55
2018 Q1 25.3M $288M +$90.6M $11.53 53
2017 Q4 16.7M $174M -$6.13M $10.36 52
2017 Q3 17.5M $280M +$1.09M $15.94 51
2017 Q2 17.5M $212M -$2.85M $12.10 47
2017 Q1 17.3M $360M +$9.74M $20.77 52
2016 Q4 17.5M $250M +$17.4M $14.30 53
2016 Q3 16.3M $268M -$17M $16.45 44
2016 Q2 14.6M $208M +$14.5M $14.26 43
2016 Q1 13.8M $198M +$197M $14.50 31